KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Shares Outstanding (2018 - 2025)

Pfizer (PFE) has disclosed Shares Outstanding for 15 consecutive years, with $9.6 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.29% to $9.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.6 billion through Dec 2025, changed 0.29% year-over-year, with the annual reading at $9.6 billion for FY2025, 0.29% changed from the prior year.
  • Shares Outstanding for Q4 2025 was $9.6 billion at Pfizer, roughly flat from $9.6 billion in the prior quarter.
  • The five-year high for Shares Outstanding was $9.6 billion in Q3 2025, with the low at $9.4 billion in Q2 2021.
  • Average Shares Outstanding over 5 years is $9.5 billion, with a median of $9.6 billion recorded in 2023.
  • The sharpest move saw Shares Outstanding soared 146.09% in 2021, then rose 0.29% in 2025.
  • Over 5 years, Shares Outstanding stood at $9.5 billion in 2021, then grew by 0.51% to $9.5 billion in 2022, then grew by 0.45% to $9.6 billion in 2023, then increased by 0.32% to $9.6 billion in 2024, then increased by 0.29% to $9.6 billion in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $9.6 billion, $9.6 billion, and $9.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.